Life Sciences Tools Market - By Technology (Cell Biology and Genomics), By Product (Flow Cytometry and Mass Spectrometry), By End-Use (Hospitals, Diagnostic Labs, Clinics, Physician Offices, and Community Units), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 05-Jul-2021 Category: Biotechnology Report Format : PDF Pages: 135 Report Code: ZMR-6449 Status : Published

The global Life Sciences Tools market accrued earnings worth approximately 93.1(USD Billion) in 2020 and is predicted to gain revenue of about 128.7(USD Billion) by 2028, is set to record a CAGR of nearly 12.2% over the period from 2021 to 2028.

Description

The global Life Sciences Tools market accrued earnings worth approximately 93.1(USD Billion) in 2020 and is predicted to gain revenue of about 128.7(USD Billion) by 2028, is set to record a CAGR of nearly 12.2% over the period from 2021 to 2028. The report offers assessment and analysis of the Life Sciences Tools market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Life Sciences Tools Market: Overview

Life science is a domain of science studying microorganisms and organisms. It encompasses fields such as molecular biology, cell biology, biomedicine, biotechnology, biochemistry, and genetics. Life sciences tools comprises of instruments, reagents, consumables, and other solutions. In addition to this, flourishing domains encompassing mass spectrometry, NMR, chromatography, and sequencing techniques will drive growth of life sciences tools industry.

Life Sciences Tools Market: Growth Drivers

Massive funding for developing bleeding edge systems for enhancing life science tools along with launching them in mainstream business will steer market trends. Humungous demand for life science tools across pharma industry will create lucrative growth avenues for life sciences tools industry in the upcoming years. Apart from this, rise in occurrence of drug resistant ailments along with large-scale spending on healthcare activities will boost expansion of life sciences tools industry size in the years to come. In addition to this, surge in incidences of cancer and other chronic diseases will proliferate growth of life sciences tools market in foreseeable future.

Moreover, increase in cases of hereditary disorders and birth defects will expedite expansion of business in the coming decade. Need for gene analysis and bringing improvement in life science devices for treating as well as curing chronic disorders will prompt industry landscape in the next couple of years. Furthermore, life science tools assist in diagnosing, monitoring, and deciphering the disease progression, thereby enlarging business scope.

Regional Landscape

North American Market To Retain Domination Over 2021-2028

The growth of life sciences tools market in North America is projected to expand leaps & bounds over forecast period subject to large-scale presence of key participants such as Thermo Fisher Scientific in the sub-continent. In addition to this, introduction of different kinds of genomic methods for clinical use in countries such as Canada and the U.S. will provide optimistic outcomes for patients and this, in turn, will popularize application of life sciences tools in field of biotechnology and life sciences.

Competitive Landscape

Key participants profiled in the study include Agilent Technologies, Danaher Corporation, Shimadzu Corporation, Oxford Instruments plc, Zeiss International, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Bruker, Merck KGaA, Illumina, Inc., Hitachi, Ltd., and QIAGEN.

The global Life Sciences Tools Market is segmented as follows:

By End-Use

  • Hospitals
  • Diagnostic Labs
  • Clinics
  • Physician Offices
  • Community Units

By Technology

  • Cell Biology
  • Genomics

By Product

  • Flow Cytometry
  • Mass Spectrometry

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Life Sciences Touls Market, 2018–2028(USD Billion)
    • 2.2. Life Sciences Touls Market: Snapshot
  • Chapter 3. Global Life Sciences Touls Market– End-Use Analysis
    • 3.1. Life Sciences Touls Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Massive funding for developing bleeding edge systems to improve life science touls coupled with launching them in mainstream business will spur market trends.
      • 3.2.2. Lucrative demand for life science touls across pharma sector will create lucrative growth opportunities for life sciences touls market in the ensuing years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By End-Use
      • 3.4.2. Market attractiveness analysis By Technulogy
      • 3.4.3. Market attractiveness analysis By Product
  • Chapter 4. Global Life Sciences Touls Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Life Sciences Touls Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Life Sciences Touls Market– End-Use Analysis
    • 5.1. Global Life Sciences Touls Market overview: By End-Use
      • 5.1.1. Global Life Sciences Touls Market share, By End-Use , 2020 and 2028
    • 5.2. Hospitals
      • 5.2.1. Global Life Sciences Touls Market by Hospitals, 2018–2028(USD Billion)
    • 5.3. Diagnostic Labs
      • 5.3.1. Global Life Sciences Touls Market by Diagnostic Labs, 2018–2028(USD Billion)
    • 5.4. Clinics
      • 5.4.1. Global Life Sciences Touls Market by Clinics, 2018–2028(USD Billion)
    • 5.5. Physician Offices
      • 5.5.1. Global Life Sciences Touls Market by Physician Offices, 2018–2028(USD Billion)
    • 5.6. Community Units
      • 5.6.1. Global Life Sciences Touls Market by Community Units, 2018–2028(USD Billion)
  • Chapter 6. Global Life Sciences Touls Market– Technulogy Analysis
    • 6.1. Global Life Sciences Touls Market overview: By Technulogy
      • 6.1.1. Global Life Sciences Touls Market share, By Technulogy, 2020 and 2028
    • 6.2. Cell Biulogy
      • 6.2.1. Global Life Sciences Touls Market by Cell Biulogy, 2018–2028(USD Billion)
    • 6.3. Genomics
      • 6.3.1. Global Life Sciences Touls Market by Genomics, 2018–2028(USD Billion)
  • Chapter 7. Global Life Sciences Touls Market– Product Analysis
    • 7.1. Global Life Sciences Touls Market overview: By Product
      • 7.1.1. Global Life Sciences Touls Market share, By Product, 2020 and 2028
    • 7.2. Flow Cytometry
      • 7.2.1. Global Life Sciences Touls Market by Flow Cytometry, 2018–2028(USD Billion)
    • 7.3. Mass Spectrometry
      • 7.3.1. Global Life Sciences Touls Market by Mass Spectrometry, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Agilent Technulogies
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Danaher Corporation
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Shimadzu Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Oxford Instruments plc
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Zeiss International
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. F. Hoffmann-La Roche AG
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfulio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Becton, Dickinson and Company
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfulio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Thermo Fisher Scientific, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfulio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Hitachi, Ltd.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfulio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Illumina, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfulio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Merck KGaA
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfulio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Bruker
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfulio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development
    • 8.13. Bio-Rad Laboratories, Inc.
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product Portfulio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Development
    • 8.14. QIAGEN
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Product Portfulio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Development

Methodology


Frequently Asked Questions

Massive funding for developing bleeding edge systems for enhancing life science tools along with launching them in mainstream business will steer market trends. Humungous demand for life science tools across pharma industry will create lucrative growth avenues for life sciences tools industry in the upcoming years. Apart from this, rise in occurrence of drug resistant ailments along with large-scale spending on healthcare activities will boost expansion of life sciences tools industry size in the years to come. In addition to this, surge in incidences of cancer and other chronic diseases will proliferate growth of life sciences tools market in foreseeable future.

Moreover, increase in cases of hereditary disorders and birth defects will expedite expansion of business in the coming decade. Need for gene analysis and bringing improvement in life science devices for treating as well as curing chronic disorders will prompt industry landscape in the next couple of years.  

According to Zion market research report, the global Life Sciences Tools market accrued earnings worth approximately 93.1(USD Billion) in 2020 and is predicted to gain revenue of about 128.7(USD Billion) by 2028, is set to record a CAGR of nearly 12.2% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to large-scale presence of key participants such as Thermo Fisher Scientific in the sub-continent. In addition to this, introduction of different kinds of genomic methods for clinical use in countries such as Canada and the U.S. will provide optimistic outcomes for patients and this, in turn, will popularize application of life sciences tools in field of biotechnology and life sciences.

 

The key market participants include Agilent Technologies, Danaher Corporation, Shimadzu Corporation, Oxford Instruments plc, Zeiss International, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Bruker, Merck KGaA, Illumina, Inc., Hitachi, Ltd., and QIAGEN.
}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com